A Phase 2 Study Evaluating JCPyV-specific T Cell Therapy for PML

Clinical trial NCT05541549 · UNKNOWN

Trial details

NCT number: NCT05541549
Sponsor: Cellevolve Bio Inc
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Progressive Multifocal Leukoencephalopathy

Start date: 2023-02-01
Primary completion: 2024-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.